Wednesday, December 9 |
Partnering with a 503B outsourced compounder is essential for many hospital pharmacies, but there are a variety of factors to weigh before choosing a vendor. In this webinar, Eric S. Kastango, MBA, RPh, FASHP, vice president and managing partner at Kastango Consulting, provides guidance to the pharmacy, including how to evaluate FDA 483s, what to look for when visiting an outsourced compounding facility, addressing drug shortages, and more.
MBA, RPh, FASHP
Eric S. Kastango, MBA, RPh, FASHP, is vice president and managing partner of the Kastango Consulting Group, a TRC Healthcare Company. He received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation.